1. Home
  2. ABAT vs KMDA Comparison

ABAT vs KMDA Comparison

Compare ABAT & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Battery Technology Company

ABAT

American Battery Technology Company

HOLD

Current Price

$3.03

Market Cap

366.2M

ML Signal

HOLD

Logo Kamada Ltd.

KMDA

Kamada Ltd.

HOLD

Current Price

$8.42

Market Cap

488.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABAT
KMDA
Founded
2011
1990
Country
United States
Israel
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
366.2M
488.6M
IPO Year
2013
2013

Fundamental Metrics

Financial Performance
Metric
ABAT
KMDA
Price
$3.03
$8.42
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$14.00
AVG Volume (30 Days)
3.0M
61.1K
Earning Date
05-15-2026
05-13-2026
Dividend Yield
N/A
2.96%
EPS Growth
43.14
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$145.40
$13.94
Revenue Next Year
N/A
$9.84
P/E Ratio
N/A
$24.59
Revenue Growth
N/A
N/A
52 Week Low
$1.02
$6.29
52 Week High
$11.49
$9.35

Technical Indicators

Market Signals
Indicator
ABAT
KMDA
Relative Strength Index (RSI) 49.84 48.73
Support Level $2.22 $8.38
Resistance Level $3.88 $8.88
Average True Range (ATR) 0.18 0.19
MACD 0.06 0.02
Stochastic Oscillator 94.92 72.22

Price Performance

Historical Comparison
ABAT
KMDA

About ABAT American Battery Technology Company

American Battery Technology Co is an integrated critical battery minerals company that develops technologies for both primary battery minerals manufacturing and lithium-ion battery recycling. It operates battery recycling facilities that process materials from electric vehicle batteries, stationary battery energy storage systems, and consumer electronics. Additionally, the company advances lithium production projects using proprietary technology to produce battery-grade lithium hydroxide. It generates revenue mainly from its recycling operations and is expanding capacity with strategic partnerships and government grants. The company's activities focus on creating a closed-loop battery materials supply chain to support sustainable manufacturing in the United States.

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

Share on Social Networks: